Wegovy, Mounjaro’s global craze has surprise winner: Korean body composition analyzer maker InBody – KED Global
Wegovy, Mounjaro’s global craze has surprise winner: Korean body composition analyzer maker InBody
InBody shares touch record highs as tracking precise changes in muscle mass versus fat loss becomes standard protocol for GLP-1 users
3
2026-07-22 11:50:50
Healthcare
As blockbuster obesity drugs like <a href="https://healthylife7.com/novo-nordisk-sues-eli-lilly-over-weight/” title=”Novo Nordisk Sues Eli Lilly Over Weight”>Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro take the world by storm, the focus of weight management is shifting toward ensuring healthy, sustainable slimming rather than simply shedding pounds.
Jongwoo Cheon edited this article.
S.Korea speeds homegrown weight-loss drug development led by Hanmi Pharm
Hanmi Pharmaceutical’s headquarters building
South Korea is racing to crack the weight-loss drug market dominated by global giants with homegrown treatments, led by Hanmi Pharmaceutical Co.’s bid to bring its first GLP-1 obesity drug to market as early as the fourth quarter, potentially i
InBody to release big data-based health management solutions
South Korea’s InBody Co., the global leader in analytic devices for body composition, is entering the health management solution field in 2023.Using its body composition data, the company will roll out products that easily check a user’s health condition at a hospital, clinic or home.InBody
InBody to expand into household, blood pressure monitoring markets
InBody founder and CEO Cha Ki-chul during an interview with The Korea Economic Daily.
South Korea’s InBody Co., the global market leader of body composition analyzer devices, will be making a strategic turn to focus on the fast-growing household segment. The company so far has been puttin
